PMV Pharmaceuticals Files 8-K with Exhibits

Ticker: PMVP · Form: 8-K · Filed: Sep 10, 2025 · CIK: 1699382

Pmv Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyPmv Pharmaceuticals, Inc. (PMVP)
Form Type8-K
Filed DateSep 10, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.00001
Sentimentneutral

Sentiment: neutral

Topics: filing, financials, exhibits

TL;DR

PMV Pharma dropped an 8-K, mostly exhibits and financials. Keep an eye out for details.

AI Summary

On September 10, 2025, PMV Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and also includes a Regulation FD Disclosure and Other Events. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing indicates PMV Pharmaceuticals is providing updated financial statements and exhibits, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a change in risk.

Key Players & Entities

  • PMV Pharmaceuticals, Inc. (company) — Registrant
  • September 10, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • 400 Alexander Park Drive, Suite 301 Princeton, NJ 08540 (address) — Principal Executive Offices

FAQ

What specific events are being disclosed under 'Other Events' in this 8-K filing?

The provided excerpt does not detail the specific events covered under 'Other Events'.

What is the significance of filing 'Financial Statements and Exhibits' in this 8-K?

Filing 'Financial Statements and Exhibits' typically means the company is providing updated financial information or supporting documents that may be material to investors.

Does the 8-K mention any new partnerships or product developments for PMV Pharmaceuticals?

The provided excerpt does not contain information about new partnerships or product developments.

What is the primary purpose of a Regulation FD Disclosure?

A Regulation FD Disclosure is made when a company intentionally or unintentionally discloses material nonpublic information to securities market participants.

What is the IRS Employer Identification Number for PMV Pharmaceuticals, Inc.?

The IRS Employer Identification Number for PMV Pharmaceuticals, Inc. is 46-3218129.

Filing Stats: 687 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2025-09-10 12:04:39

Key Financial Figures

  • $0.00001 — ange on which registered Common Stock, $0.00001 par value per share PMVP The Nasdaq

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits : Exhibit Number Description 99.1 Investor Webinar dated September 10, 2025 99.2 Press Release issued by PMV Pharmaceuticals, Inc., dated September 10, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PMV Pharmaceuticals, Inc. Date: September 10, 2025 By: /s/ Michael Carulli Michael Carulli Chief Financial Officer (Principal Financial Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.